Curetis Publishes Business and Financial Update for the First Nine Months of 2017 – Preparing for expected U.S. FDA clearance decision on Unyvero System and Unyvero […]

Curetis initiates U.S. FDA Study for Unyvero Invasive Joint Infections Cartridge –      Initial patient samples collected for second U.S. Unyvero Product Study –      Prospective clinical trial expected to […]

MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics –        Broad collaboration to develop a targeted Next-Generation Sequencing assay for microbial infections –        Workflow for native samples […]

BERLIN, and GERMANTOWN, Md., Aug. 30, 2017 /PRNewswire/ — Epigenomics AG (Frankfurt Prime Standard: ECX) (OTCQX: EPGNY), today announced the initiation of a Post Approval Study […]

  – Trial sponsored by University Clinic RWTH Aachen investigates personalized treatment approaches with Biotest’s Pentaglobin® in peritonitis patients – Curetis to provide testing services for […]

Curetis Provides Update on Unyvero LRT FDA 510(k) Submission – Curetis reiterates that it expects FDA to provide decision on clearance of Unyvero LRT in the […]

Curetis Files for U.S. FDA Clearance for Unyvero Platform and LRT Application Cartridge – Final panel demonstrates overall weighted average sensitivity of 91.4% and overall weighted […]

Curetis Completes Development of Unyvero Cartridge for Intra-Abdominal Infections – Highly multiplexed panel covers up to 112 diagnostic targets – Third new panel developed within one […]

Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec – Gyronimo Platform offers rapid, quantitative cartridge-based sample-to-answer molecular diagnostic testing – Gyronimo to be fully integrated […]